Literature DB >> 19636196

Calcitonin assay in wash-out fluid after fine-needle aspiration biopsy in patients with a thyroid nodule and border-line value of the hormone.

F Massaro1, M Dolcino, R Degrandi, D Ferone, M Mussap, F Minuto, M Giusti.   

Abstract

Assaying calcitonin (CT) in the wash-out fluid from fine-needle aspiration biopsies (CT-FNAB) could be useful in the diagnosis of medullary thyroid carcinoma (MTC). The aim of this study was to correlate serum CT with cytology and CT-FNAB. Twenty-seven subjects (age range 27-75 yr) were studied. FNAB was performed in a thyroid nodule (no.=16) or lymph-node (no.=1 previously operated on for MTC) or in the prevalent nodule of multinodular goiters (no.=10). CT-FNAB values obtained in 37 subjects with normal serum CT (<10 ng/l) who underwent FNAB for thyroid nodules served as a negative control. In these subjects, CTFNAB values were 8.2+/-6.4 ng/l (range 2-30 ng/l). In patients with a thyroid nodule under evaluation for MTC, serum CT and CT-FNAB values were 14.5+/-3.9 ng/l (range 10-24 ng/l) and 16.4+/-29.8 ng/l (range 2-144 ng/l), respectively. In 4 patients, CT-FNAB values were higher than the highest values found in our negative controls (30 ng/l), but cytology results were compatible with a benign thyroid lesion and pentagastrin testing was negative. In 3 cases with CT-FNAB <30 ng/l, cytology was indicative of an indeterminate or probably follicular malignant lesion and histology was negative for MTC. None of the other subjects in whom pentagastrin testing was conducted showed serum CT values >100 ng/l. Our data do not show any correlation between CT-FNAB and serum CT. In conclusion, borderline CT values in patients with thyroid nodules are not rare. Our experience suggests that CT-FNAB does not have the same importance as that reported in the literature for thyroglobulin and PTH assay in wash-out fluid after FNAB in malignant thyroid and hyperfunctioning parathyroid lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19636196     DOI: 10.1007/BF03345717

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

1.  Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases.

Authors:  J R Hahm; M S Lee; Y K Min; M K Lee; K W Kim; S J Nam; J H Yang; J H Chung
Journal:  Thyroid       Date:  2001-01       Impact factor: 6.568

2.  Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Steven I Sherman; R Michael Tuttle
Journal:  Thyroid       Date:  2006-02       Impact factor: 6.568

3.  The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies.

Authors:  F Boi; G Baghino; F Atzeni; M L Lai; G Faa; S Mariotti
Journal:  J Clin Endocrinol Metab       Date:  2006-01-24       Impact factor: 5.958

4.  Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer.

Authors:  F Pacini; L Fugazzola; F Lippi; C Ceccarelli; R Centoni; P Miccoli; R Elisei; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  1992-06       Impact factor: 5.958

5.  The rational use of fine needle aspiration biopsy (FNAB) in diagnosing thyroid nodules.

Authors:  M Sidoti; G Marino; E Resmini; C Augeri; C Cappi; D Cavallero; C Lagasio; P Ceppa; F Minuto; M Giusti
Journal:  Minerva Endocrinol       Date:  2006-06       Impact factor: 2.184

6.  Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.

Authors:  F Pacini; M Fontanelli; L Fugazzola; R Elisei; C Romei; G Di Coscio; P Miccoli; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  1994-04       Impact factor: 5.958

7.  US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer.

Authors:  R T Sutton; C C Reading; J W Charboneau; E M James; C S Grant; I D Hay
Journal:  Radiology       Date:  1988-09       Impact factor: 11.105

8.  Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma.

Authors:  Francesco Boi; Ivan Maurelli; Giovanni Pinna; Francesca Atzeni; Mario Piga; Maria Letizia Lai; Stefano Mariotti
Journal:  J Clin Endocrinol Metab       Date:  2007-04-03       Impact factor: 5.958

9.  C-cell hyperplasia in secondary hyperparathyroidism.

Authors:  T Tomita; D M Millard
Journal:  Histopathology       Date:  1992-11       Impact factor: 5.087

10.  Ultrasound guided fine needle aspiration biopsy of parathyroid gland and lesions.

Authors:  Haytham Dimashkieh; Savitri Krishnamurthy
Journal:  Cytojournal       Date:  2006-03-28       Impact factor: 2.091

View more
  3 in total

1.  Is there a real diagnostic impact of elastosonography and contrast-enhanced ultrasonography in the management of thyroid nodules?

Authors:  Massimo Giusti; Davide Orlandi; Giulia Melle; Barbara Massa; Enzo Silvestri; Francesco Minuto; Gianni Turtulici
Journal:  J Zhejiang Univ Sci B       Date:  2013-03       Impact factor: 3.066

Review 2.  Thyroid nodules in pediatrics: which ones can be left alone, which ones must be investigated, when and how.

Authors:  Andrea Corrias; Alessandro Mussa
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013

3.  Calcitonin measurement in fine-needle aspirate washouts vs. cytologic examination for diagnosis of primary or metastatic medullary thyroid carcinoma.

Authors:  C de Crea; M Raffaelli; D Maccora; C Carrozza; G Canu; G Fadda; R Bellantone; C P Lombardi
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-12       Impact factor: 2.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.